CPhI Prepares for India - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

CPhI Prepares for India


CPhI ands its collocated events take place in various other locations outside of Europe. Following the event’s departure from Madrid, it will only be a few weeks before pharmaceutical professionals are once again networking under the CPhI name; this time in Mumbai for CPhI India.

CPhI India will take place on 21–23 November at the Bombay Exhibition Centre and will also celebrate its sixth anniversary. According to the organisers, the Indian pharmaceutical market is growing at an annual rate of 13%, twice that of the global market growth rate.

Last year’s event featured 825 exhibitors from 21 countries and regions and more than 27000 attendees from 96 countries and regions. Visitor levels are not far behind CPhI Worldwide, which has been running for considerably longer than its Indian sister event.

CPhI India will also feature some of the same collocated events that are seen at the European show: P-MEC for pharmaceutical machinery, equipment and technology; ICSE for pharmaceutical contract services and outsourcing solutions; and BioPh for bio-solutions for pharma.

You can find out more about CPhI India here.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
26%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
10%
All of the above.
43%
No government involvement in patient treatment or drug development.
10%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here